Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-008927

Chief Financial Officer sold 20,000 shares at an average $31.52 ($630,308)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-02-10 Option exercise +20,000 $4.07 $81,400 21,000 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2020-02-10 Sale −3,279 $31.90 $104,600 17,721 D: show line 2 in the form
Cohen Chad M Chief Financial Officer 2020-02-10 Sale −16,721 $31.44 $525,708 1,000 D: show line 3 in the form
Open-market sales · 20,000 sh · avg $31.52 · $630,308

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Chad M Chief Financial Officer 2020-02-10 Option exercise · Stock Option (Right to Buy) −20,000 60,000 D: show line 4 in the form
Loading xslF345X03/doc4.xml…